A polymorphic variant of the human ␣ 2B -adrenergic receptor (␣ 2B AR), which consists of a deletion of three glutamic acids (residues 301-303) in the third intracellular loop was found to be common in Caucasians (31%) and to a lesser extent in African-Americans (12%). The consequences of this deletion were assessed by expressing wild-type and the Del301-303 receptors in Chinese hamster ovary and COS cells. Ligand binding was not affected, although a small decrease in coupling efficiency to the inhibition of adenylyl cyclase was observed with the mutant. The deletion occurs within a stretch of acidic residues that is thought to establish the milieu for agonist-promoted phosphorylation and desensitization of the receptor by G protein-coupled receptor kinases (GRKs). Agonist-promoted phosphorylation studies carried out in cells coexpressing the ␣ 2B ARs and GRK2 revealed that the Del301-303 receptor displayed ϳ56% of wild-type phosphorylation. Furthermore, the depressed phosphorylation imposed by the deletion was found to result in a complete loss of short term agonistpromoted receptor desensitization. Thus the major phenotype of the Del301-303 ␣ 2B AR is one of impaired phosphorylation and desensitization by GRKs, and thus the polymorphisms renders the receptor incapable of modulation by this key mechanism of dynamic regulation.␣ 2 -Adrenergic receptors (␣ 2 AR) 1 are cell surface receptors for catecholamines that bind to the G i /G o family of G proteins, coupling to multiple effector systems including inhibition of adenylyl cyclase activity (1). ␣ 2 AR are widely expressed within the central and peripheral nervous system (2-4) and participate in a broad spectrum of physiologic functions such as regulation of blood pressure both centrally and within the vasculature, sedation, analgesia, regulation of insulin release, renal function, and cognitive and behavioral functions (5-12). Three human ␣ 2 AR subtypes have been cloned and characterized (␣ 2A , ␣ 2B , and ␣ 2C ). The ␣ 2B AR has a distinct pattern of expression within the brain, liver, lung, and kidney, and recent studies using gene knockouts in mice have shown that disruption of this receptor effects mouse viability (13), blood pressure responses to ␣ 2 AR agonists (13), and the hypertensive response to salt loading (14).Like the ␣ 2A AR subtype (15, 16), the ␣ 2B AR undergoes short term agonist promoted desensitization (17). This desensitization is due to phosphorylation of the receptor, which evokes a partial uncoupling of the receptor from functional interaction with G i /G o (18,19). Such phosphorylation appears to be due to G protein-coupled receptor kinases (GRKs), a family of serine/ threonine kinases that phosphorylate the agonist-occupied conformations of many G protein-coupled receptors (20). The process serves to finely regulate receptor function providing for rapid adaptation of the cell to its environment. Desensitization may also limit the therapeutic effectiveness of administered agonists. For the ␣ 2B AR, phosphorylation of serines/threonine...